Lineage Cell Therapeutics, Inc.
Shares Outstanding
| Fiscal Year | Shares Outstanding |
|---|---|
| FY2019 | 149.8M |
| FY2020 | 153.1M |
| FY2021 | 164.5M |
| FY2022 | 169.8M |
| FY2023 | 172.7M |
Shares Outstanding
| Fiscal Year | Shares Outstanding |
|---|---|
| FY2019 | 149.8M |
| FY2020 | 153.1M |
| FY2021 | 164.5M |
| FY2022 | 169.8M |
| FY2023 | 172.7M |